Abstract
Asthma is a pathophysiological condition associated with eosinophilia and heightened inflammatory reactions, epithelial desquamation, hyper responsiveness, recurring episodes of reversible broncho-constriction, and mucus hyper secretion from the respiratory organs. Asthma interludes can be triggered by a variety of factors most notably allergens, infectious agents, pollutants, and nonspecific stimuli such as exercise, nutritional factors and emotional stress. Certain genes and their polymorphism may also have effects in the initiation and progression of asthma. Thus asthma may also be classified as atopic (extrinsic) or non-atopic (intrinsic). Here atopy refers to a predisposition towards developing type 1 hypersensitivity reactions. In a present day scenario asthma is termed as a complex genetic disorder with a heterogeneous phenotype, largely attributed to the interactions between genes and/or environment. Hence, pharmacogenomics is an important area to understand the influence of genetic variations on drug response in asthmatics by correlating gene expression or single-nucleotide polymorphisms (SNPs) with drug's efficacy. This article reviews the role of various genes and their polymorphism in initiation, complication of asthma and its treatment strategies focussing on disease causing polymorphic and novel genes.
Keywords: Asthma, eosinophilia, genetic polymorphism, novel genes, pharmacogenomics.
Current Respiratory Medicine Reviews
Title:Recent Advances in Asthma Genetics and Antiasthma Therapy
Volume: 9 Issue: 4
Author(s): Daizee Talukdar, Narender Chaudhry, Rohit Sharma, Raman Kumar and Tapan K. Mukherjee
Affiliation:
Keywords: Asthma, eosinophilia, genetic polymorphism, novel genes, pharmacogenomics.
Abstract: Asthma is a pathophysiological condition associated with eosinophilia and heightened inflammatory reactions, epithelial desquamation, hyper responsiveness, recurring episodes of reversible broncho-constriction, and mucus hyper secretion from the respiratory organs. Asthma interludes can be triggered by a variety of factors most notably allergens, infectious agents, pollutants, and nonspecific stimuli such as exercise, nutritional factors and emotional stress. Certain genes and their polymorphism may also have effects in the initiation and progression of asthma. Thus asthma may also be classified as atopic (extrinsic) or non-atopic (intrinsic). Here atopy refers to a predisposition towards developing type 1 hypersensitivity reactions. In a present day scenario asthma is termed as a complex genetic disorder with a heterogeneous phenotype, largely attributed to the interactions between genes and/or environment. Hence, pharmacogenomics is an important area to understand the influence of genetic variations on drug response in asthmatics by correlating gene expression or single-nucleotide polymorphisms (SNPs) with drug's efficacy. This article reviews the role of various genes and their polymorphism in initiation, complication of asthma and its treatment strategies focussing on disease causing polymorphic and novel genes.
Export Options
About this article
Cite this article as:
Talukdar Daizee, Chaudhry Narender, Sharma Rohit, Kumar Raman and Mukherjee K. Tapan, Recent Advances in Asthma Genetics and Antiasthma Therapy, Current Respiratory Medicine Reviews 2013; 9 (4) . https://dx.doi.org/10.2174/1573398X09666131217002352
DOI https://dx.doi.org/10.2174/1573398X09666131217002352 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pathophysiological Bases of Eosinophilic Esophagitis Therapy
Inflammation & Allergy - Drug Targets (Discontinued) Edtorial [Hot topic: Glucocorticoids from Chemistry to Clinics (Executive Editor: Fortunato Vesce)]
Current Pharmaceutical Design Molecular Hybrids of N-Phthaloylglycyl Hydrazide and Hydrazinecarbothioamide with Anti-inflammatory and Anti-oxidant Activities
Current Organic Synthesis The Innate Immune System and Fever under Redox Control: A Narrative Review
Current Medicinal Chemistry Randomized Clinical Trials in Children - Ethical and Methodological Issues
Current Pharmaceutical Design A Comprehensive Review on Exosomes and Microvesicles as Epigenetic Factors
Current Stem Cell Research & Therapy Role of Endogenous Granulocyte-Macrophage Colony Stimulating Factor Following Stroke and Relationship to Neurological Outcome
Current Neurovascular Research A Pulmonary Perspective on GASPIDs: Granule-Associated Serine Peptidases of Immune Defense
Current Respiratory Medicine Reviews Enkephalinase Inhibitors: Potential Agents for the Management of Pain
Current Drug Targets Exosomal MicroRNA: Diagnostic Marker and Therapeutic Tool for Lung Diseases
Current Pharmaceutical Design Recent Inventions in Powder Technology and Granular Science Incorporating Improved Drug Delivery
Recent Patents on Engineering Noscapine and its Analogs as Chemotherapeutic Agent: Current updates
Current Topics in Medicinal Chemistry Informing People about the Risks and Benefits of Medicines: Implications for the Safe and Effective Use of Medicinal Products
Current Drug Safety Correlations and Influence of TAP2 Genes Polymorphisms and Systemic Lupus Erythematosus Propensity
Current Rheumatology Reviews Advances in Immunological Treatment of Allergy
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Recent Patents on Metalloproteinases as Biomarkers in Osteoarthritis Diagnosis and Treatment
Recent Patents on Biomarkers Nanoparticle Interaction with Biomolecules: How it Shapes the Nano-Effects on Immunity
Current Bionanotechnology (Discontinued) COVID-19 Treatment Success After Repeat Courses of Azithromycin: A Report of Three Cases
Infectious Disorders - Drug Targets The Pentacyclic Triterpenoids in Herbal Medicines and Their Pharmacological Activities in Diabetes and Diabetic Complications
Current Medicinal Chemistry T Cell-based Therapies for Atherosclerosis
Current Pharmaceutical Design